Literature DB >> 29699690

Spatiotemporal Modulation of ERK Activation by GPCRs.

Uchenna Watson1, Ruchi Jain2, Suramya Asthana2, Deepak K Saini3.   

Abstract

ERK1/2 (extracellular signal-regulated protein kinases) are the nodal proteins that regulate diverse cellular functions primarily in response to activation from receptor tyrosine kinases (RTKs). Not only is ERK activated through a variety of RTKs, but noncanonical signaling through GPCRs also activates them. Such multimodal activation allows appropriate integration of many inputs to critical cell fate decisions such as proliferation and differentiation that MAP kinases typically regulate. MAP kinases also regulate many polar responses such as apoptosis and proliferation, dedifferentiation-differentiation, and the diversity in the outcomes though the same terminal molecule can be explained based on differences in the activation dynamics and rates. However, two processes have now been established as drivers for most of the diversity recorded in the outcomes of MAP kinase signaling. These parameters are cellular compartmentalization, i.e., spatial confinement of the molecules participating in a pathway and changes in the kinetics of the activation-deactivation, i.e., temporal regulation. While phosphorylation is the key to activating responses, specifically for ERK, the terminal MAP kinase, it is the spatiotemporal dynamics that governs the outcome generated by it. This chapter reviews our present understanding of the spatial and temporal regulation of MAP kinase cascade and the ERK activity, specifically through GPCRs.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GPCR; MAP kinase; Noncanonical; Scaffold; Spatiotemporal regulation

Mesh:

Substances:

Year:  2018        PMID: 29699690     DOI: 10.1016/bs.ircmb.2018.02.004

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  3 in total

1.  ERK1/2 communicates GPCR and EGFR signaling pathways to promote CTGF-mediated hypertrophic cardiomyopathy upon Ang-II stimulation.

Authors:  Xin Liu; Lin Lin; Qing Li; Yajuan Ni; Chaoying Zhang; Shuguang Qin; Jin Wei
Journal:  BMC Mol Cell Biol       Date:  2019-06-14

Review 2.  Mutations That Confer Drug-Resistance, Oncogenicity and Intrinsic Activity on the ERK MAP Kinases-Current State of the Art.

Authors:  Karina Smorodinsky-Atias; Nadine Soudah; David Engelberg
Journal:  Cells       Date:  2020-01-06       Impact factor: 6.600

3.  Curcumin promotes oligodendrocyte differentiation and their protection against TNF-α through the activation of the nuclear receptor PPAR-γ.

Authors:  Antonietta Bernardo; Cristina Plumitallo; Chiara De Nuccio; Sergio Visentin; Luisa Minghetti
Journal:  Sci Rep       Date:  2021-03-02       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.